Abstract:Background Immunotherapy for hepatocellular carcinoma (HCC) exhibits limited clinical efficacy due to immunosuppressive tumor microenvironment (TME). Tumor-infiltrating macrophages (TIMs) account for the major component in the TME, and the dominance of M2 phenotype over M1 phenotype in the TIMs plays the pivotal role in sustaining the immunosuppressive character. We thus investigate the effect of bufalin on promoting TIMs polarization toward M1 phenotype to improve HCC immunotherapy. Methods The impact of bufalin on evoking antitumor immune response was evaluated in the immunocompetent mouse HCC model. The expression profiling of macrophage-associated genes, surface markers and cytokines on bufalin treatment in vitro and in vivo were detected using flow cytometry, immunofluorescence, western blot analysis, ELISA and RT-qPCR. Cell signaling involved in M1 macrophage polarization was identified via the analysis of gene sequencing, and bufalin-governed target was explored by immunoprecipitation, western blot analysis and gain-and-loss of antitumor immune response. The combination of bufalin and antiprogrammed cell death protein 1 (anti-PD-1) antibody was also assessed in orthotopic HCC mouse model. Results In this study, we showed that bufalin can function as an antitumor immune modulator that governs the polarization of TIMs from tumor-promoting M2 toward tumor-inhibitory M1, which induces HCC suppression through the activation of effector T cell immune response. Mechanistically, bufalin inhibits overexpression of p50 nuclear factor kappa B (NF-κB) factor, leading to the predominance of p65-p50 heterodimers over p50 homodimers in the nuclei. The accumulation of p65-p50 heterodimers activates NF-κB signaling, which is responsible for the production of immunostimulatory cytokines, thus resulting in the activation of antitumor T cell immune response. Moreover, bufalin enhances the antitumor activity of anti-PD-1 antibody, and the combination exerts synergistic effect on HCC suppression. Conclusions These data expound a novel antitumor mechanism of bufalin, and facilitate exploitation of a new potential macrophage-based HCC immunotherapeutic modality.

Bufalin Inhibits Migration and Invasion in Human Hepatocellular Carcinoma SK-Hep1 Cells Through the Inhibitions of NF-kB and Matrix Metalloproteinase-2/-9-signaling Pathways.

Bufalin Inhibits NCI-H460 Human Lung Cancer Cell Metastasis in Vitro by Inhibiting MAPKs, MMPs, and NF-κB Pathways.

Bufalin Suppresses Hepatocellular Carcinoma Invasion and Metastasis by Targeting HIF-1α Via the PI3K/AKT/mTOR Pathway.

Bufalin Inhibits Htert Expression and Colorectal Cancer Cell Growth by Targeting CPSF4

Bufalin‐inhibited Migration and Invasion in Human Osteosarcoma U‐2 OS Cells is Carried out by Suppression of the Matrix Metalloproteinase‐2, ERK, and JNK Signaling Pathways

Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice

Bufalin Inhibits Gefitinib Resistant NCI-H460 Human Lung Cancer Cell Migration and Invasion in Vitro.

Bufalin Increases Sensitivity to Akt/Mtor-Induced Autophagic Cell Death in Sk-Hep-1 Human Hepatocellular Carcinoma Cells

Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells

Inhibition Effect of Bufalin on Invasion and Metastasis of Gastric Cancer Cells

Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma Via Modulating the ATP1A1/CA2 Axis

Bufalin Inhibits Tgf-Beta-Induced Epithelial-To-Mesenchymal Transition And Migration In Human Lung Cancer A549 Cells By Downregulating Tgf-Beta Receptors

Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model Through Genes Related to Apoptotic and PTEN/AKT Pathways

Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling

Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway

Bufalin attenuates the proliferation of breast cancer MCF-7 cells in vitro and in vivo by inhibiting the PI 3 K / Akt pathway

Bufalin, a Traditional Chinese Medicine Compound, Prevents Tumor Formation in Two Murine Models of Colorectal Cancer

Bufalin Suppresses the Migration and Invasion of Prostate Cancer Cells Through HOTAIR, the Sponge of Mir-520B

Bufalin Suppresses Tumour Microenvironment-Mediated Angiogenesis by Inhibiting the STAT3 Signalling Pathway